Breaking News Instant updates and real-time market news.

AMRN

Amarin

$19.38

0.06 (0.31%)

, RDY

Dr. Reddy's

$41.63

-0.25 (-0.60%)

08:15
01/16/20
01/16
08:15
01/16/20
08:15

Amarin in 'good position' as 'heated' patent trial continues, says Jefferies

Jefferies analyst Michael Yee said the third day of Amarin's (AMRN) patent trial versus Hikma and Dr. Reddy's (RDY) focused on the claim of nonobviousness and examination of the defense's witness, adding that cross-examination "went well" in his view for Amarin. Barring some new evidence or "radical interpretation" by Judge Miranda Du, Yee thinks Amarin is in a "good position" and believes the company is likely to prevail on upholding the patent given his view that the burden of proof is "already high" for obviousness. The analyst, who noted that the trial will last until the end of January and a decision is expected around March or April, has a Buy rating on Amarin shares.

AMRN

Amarin

$19.38

0.06 (0.31%)

RDY

Dr. Reddy's

$41.63

-0.25 (-0.60%)

  • 27

    Jan

AMRN Amarin
$19.38

0.06 (0.31%)

01/10/20
ROTH
01/10/20
NO CHANGE
Target $31
ROTH
Buy
Amarin set up for strong partnership interest in the EU, says Roth Capital
Roth Capital analyst Yasmeen Rahimi says Amarin's continued news flow in early 2020, especially around approval of Vascepa by Health Canada and this week's continued strong guidance update, marks strong execution by the Amarin team as it keeps focused on U.S. commercialization in 2020. With a broad label in Canada that looks similar to FDA approval, Rahimi sees Amarin set up for strong partnership interest in the EU and remaining geographies. The analyst made no change to her Buy rating and $31 price target.
01/13/20
JPMS
01/13/20
NO CHANGE
JPMS
Epanova discontinuation positive for Amarin, says JPMorgan
JPMorgan analyst Jessica Fye views the removal of Epanova as a positive for Amarin (AMRN). AstraZeneca (AZN) said this morning that it is closing the Phase III trial for Epanova in mixed dyslipidaemia following the recommendation from an independent Data Monitoring Committee. Epanova is an omega-3 carboxylic acid and was being studied to demonstrate a possible benefit in patients with mixed dyslipidaemia who are at increased risk of cardiovascular disease. Shares of Amarin are up 6%, or $1.07, to $20.02 in premarket trading.
01/13/20
STFL
01/13/20
NO CHANGE
Target $28
STFL
Hold
Amarin should rally on failure of two potential competitors, says Stifel
Stifel analyst Derek Archila expects shares of Amarin (AMRN) to be up today on news that AstraZeneca (AZN) discontinued Epanova's STRENGTH cardiovascular outcomes trial given the low likelihood it would demonstrate a cardiovascular benefit. While the STRENGTH study had a low probability of a positive outcome, its failure "no doubt reinforces the importance" of the pure eicosapentaenoic acid hypothesis and Vascepa's REDUCE-IT results, Archila tells investors in a research note. In addition, Acasti Pharma (ACST) reported that its Phase 3 TRILOGY 1 study results for its lead candidate, CaPre, in patients with hypertriglyceridemia failed, Archila points out. He notes that this program was also viewed as a potential competitor to Amarin's Vascepa. The analyst believes that with both of these failures, investor fears over near-to-medium term branded competition to Vaspeca should subside. Archila has a Hold rating on Amarin with a $28 price target. The stock in premarket trading is up 6% to $20.05.
01/13/20
ROTH
01/13/20
NO CHANGE
ROTH
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
Roth Capital analyst Yasmeen Rahimi maintained a Buy rating and $31 price target on Amarin (AMRN) following the failures of two competitors to Amarin's Vascepa -- those being the discontinuation of AstraZeneca's (AZN) Epanova trial and the negative TRIOLOGY 1 data from Acasti Pharma's (ACST) CaPre -- which leaves Vascepa as the "'go-to' omega-3 product" and kills the central bear case against Amarin.
RDY Dr. Reddy's
$41.63

-0.25 (-0.60%)

09/04/19
09/04/19
UPGRADE

Outperform
Dr. Reddy's upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Anubhav Aggarwal upgraded Dr. Reddy's to Outperform from Underperform saying that while his previous concerns were high market expectations from Copaxone and Nuvaring, the stock is now at the other extreme, and ignoring the aforementioned drugs, it has a "strong" U.S. pipeline and multiple option values. His analysis shows the company has multiple drugs of $15M-$35M opportunity, which should help its base U.S. sales to continue to grow.
11/04/19
BOFA
11/04/19
DOWNGRADE
BOFA
Neutral
Dr. Reddy's downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill downgraded Dr. Reddy's to Neutral from Buy.
01/09/20
SBSH
01/09/20
UPGRADE
SBSH
Buy
Dr. Reddy's upgraded to Buy from Sell at Citi
Citi upgraded Dr. Reddy's to Buy from Sell.
01/09/20
SBSH
01/09/20
UPGRADE
SBSH
Buy
Citi double upgrades Dr. Reddy's to Buy as Indian pharma view improves
Citi analyst Preshant Nair upgraded Dr. Reddy's two notches, to Buy from Sell, as he believes there is "more to look forward to in the Indian pharma space now" than in the past few years. The biggest drag, the U.S. generics business, appears to have stabilized and growth in India should pick up off a low base, contends the analyst, who also points to "more reasonable" valuations in the group.

TODAY'S FREE FLY STORIES

DGLY

Digital Ally

$0.94

(0.00%)

17:27
01/21/20
01/21
17:27
01/21/20
17:27
Syndicate
Breaking Syndicate news story on Digital Ally »

Digital Ally files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$165.54

-1.03 (-0.62%)

17:24
01/21/20
01/21
17:24
01/21/20
17:24
Downgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AES

AES Corp.

$20.47

-0.02 (-0.10%)

17:23
01/21/20
01/21
17:23
01/21/20
17:23
Hot Stocks
AES Corp's sPower suspends Seneca wind project »

sPower announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTFC

Wintrust Financial

$66.90

-2.03 (-2.95%)

17:20
01/21/20
01/21
17:20
01/21/20
17:20
Earnings
Wintrust Financial reports Q4 EPS $1.44, consensus $1.58 »

For the fourth quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

SKT

Tanger Factory

$15.93

0.56 (3.64%)

, MDR

McDermott

$0.70

(0.00%)

17:18
01/21/20
01/21
17:18
01/21/20
17:18
Hot Stocks
Tanger Factory to replace McDermott in S&P 600 at open on 1/27 »

McDermott International…

SKT

Tanger Factory

$15.93

0.56 (3.64%)

MDR

McDermott

$0.70

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIT

CIT Group

$45.23

-1.17 (-2.52%)

, SKT

Tanger Factory

$15.93

0.56 (3.64%)

17:17
01/21/20
01/21
17:17
01/21/20
17:17
Hot Stocks
Breaking Hot Stocks news story on CIT Group, Tanger Factory »

CIT Group to replace…

CIT

CIT Group

$45.23

-1.17 (-2.52%)

SKT

Tanger Factory

$15.93

0.56 (3.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

IBM

IBM

$139.15

0.84 (0.61%)

17:15
01/21/20
01/21
17:15
01/21/20
17:15
Hot Stocks
IBM says there is continued momentum in hybrid cloud »

Says significant actions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

TKTDY

Takata

$0.00

(0.00%)

, HMC

Honda

$27.60

-0.18 (-0.65%)

17:12
01/21/20
01/21
17:12
01/21/20
17:12
Periodicals
Honda to recall 2.4M older U.S. cars over faulty air bag inflators, Reuters says »

Honda (HMC) said it plans…

TKTDY

Takata

$0.00

(0.00%)

HMC

Honda

$27.60

-0.18 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$59.95

-0.725 (-1.19%)

17:10
01/21/20
01/21
17:10
01/21/20
17:10
Downgrade
Rio Tinto rating change  »

Rio Tinto downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNST

Renasant

$35.37

-0.23 (-0.65%)

17:08
01/21/20
01/21
17:08
01/21/20
17:08
Earnings
Renasant reports Q4 EPS 67c, consensus 66c »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

LYFT

Lyft

$47.91

1.33 (2.86%)

17:07
01/21/20
01/21
17:07
01/21/20
17:07
Hot Stocks
Lyft, LeBron James partner to expand bikeshare access across U.S. »

Lyft announced that it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Feb

AMTD

TD Ameritrade

$50.76

0.25 (0.49%)

, TD

Toronto-Dominion

$56.55

-0.18 (-0.32%)

17:02
01/21/20
01/21
17:02
01/21/20
17:02
Earnings
TD Bank comments on expected impact of TD Ameritrade's Q1 earnings »

TD Bank (TD) announced…

AMTD

TD Ameritrade

$50.76

0.25 (0.49%)

TD

Toronto-Dominion

$56.55

-0.18 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCBI

United Community Banks

$29.75

-0.6 (-1.98%)

17:02
01/21/20
01/21
17:02
01/21/20
17:02
Earnings
United Community Banks reports Q4 EPS 61c, consensus 58c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

OBE

Obsidian Energy

$0.87

-0.0616 (-6.61%)

17:02
01/21/20
01/21
17:02
01/21/20
17:02
Hot Stocks
Obsidian Energy reports FY19 production 26,900 boe/d »

Obsidian Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMBK

SmartFinancial

$22.97

-0.35 (-1.50%)

17:01
01/21/20
01/21
17:01
01/21/20
17:01
Earnings
SmartFinancial reports Q4 operating EPS 46c, consensus 40c »

Billy Carroll, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

TTWO

Take-Two

$130.40

0.42 (0.32%)

17:00
01/21/20
01/21
17:00
01/21/20
17:00
Periodicals
Grand Theft Auto V maker Rockstar claimed tax relief in 2019, Telegraph says »

Matthew Field of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

BA

Boeing

$313.31

-10.8 (-3.33%)

, WJAFF

WestJet

$0.00

(0.00%)

16:59
01/21/20
01/21
16:59
01/21/20
16:59
Hot Stocks
WestJet makes statement on Boeing 737 MAX »

Following Boeing's…

BA

Boeing

$313.31

-10.8 (-3.33%)

WJAFF

WestJet

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

MGM

MGM Resorts

$32.37

-2.16 (-6.26%)

, AAL

American Airlines

$27.21

-1.18 (-4.16%)

16:51
01/21/20
01/21
16:51
01/21/20
16:51
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

Sentiment in the stock…

MGM

MGM Resorts

$32.37

-2.16 (-6.26%)

AAL

American Airlines

$27.21

-1.18 (-4.16%)

BA

Boeing

$313.31

-10.8 (-3.33%)

LVS

Las Vegas Sands

$70.06

-4.01 (-5.41%)

WYNN

Wynn Resorts

$142.21

-9.3 (-6.14%)

MLCO

Melco Resorts & Entertainment

$22.61

-2.4 (-9.60%)

HAL

Halliburton

$23.77

-0.19 (-0.79%)

VFC

VF Corp.

$94.63

0.38 (0.40%)

DAL

Delta Air Lines

$60.35

-1.66 (-2.68%)

UAL

United Airlines

$85.84

-3.84 (-4.28%)

TSLA

Tesla

$547.43

37.09 (7.27%)

OMI

Owens & Minor

$6.50

0.98 (17.75%)

BYND

Beyond Meat

$129.24

20.04 (18.35%)

SBUX

Starbucks

$92.54

-1.08 (-1.15%)

ARWR

Arrowhead

$47.63

-8.79 (-15.58%)

WW

WW

$37.55

-4.38 (-10.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 21

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 28

    Jan

  • 29

    Jan

  • 29

    Jan

  • 12

    Feb

  • 24

    Feb

  • 04

    Mar

  • 23

    Mar

  • 23

    Mar

OPTT

Ocean Power

$0.89

-0.0293 (-3.20%)

16:43
01/21/20
01/21
16:43
01/21/20
16:43
Syndicate
Breaking Syndicate news story on Ocean Power »

Ocean Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADPT

Adaptive Biotechnologies

$26.87

-1.2 (-4.28%)

16:41
01/21/20
01/21
16:41
01/21/20
16:41
Syndicate
Adaptive Biotechnologies files to sell 8M shares of common stock for holders »

J.P. Morgan, Goldman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$30.64

0.65 (2.17%)

16:40
01/21/20
01/21
16:40
01/21/20
16:40
Syndicate
Elanco announces offerings of 19.16M shares of common stock, 11M units »

Elanco Animal Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

MNLO

Menlo Therapeutics

$6.47

-0.18 (-2.71%)

16:39
01/21/20
01/21
16:39
01/21/20
16:39
Hot Stocks
Point72 discloses 5.8% passive stake in Menlo Therapeutics »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

APLT

Applied Therapeutics

$48.18

-0.35 (-0.72%)

16:38
01/21/20
01/21
16:38
01/21/20
16:38
Syndicate
Applied Therapeutics files to sell 1.75M shares of common stock »

Goldman Sachs & Co.,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

ZLAB

Zai Lab

$52.13

-1.07 (-2.01%)

16:36
01/21/20
01/21
16:36
01/21/20
16:36
Syndicate
Zai Lab announces offering of 5.5M ADSs »

Zai Lab Limited announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEIX

Pacific Ethanol

$0.68

-0.005 (-0.73%)

16:34
01/21/20
01/21
16:34
01/21/20
16:34
Syndicate
Breaking Syndicate news story on Pacific Ethanol »

Pacific Ethanol files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.